AKVEDA Trademark

Trademark Overview

On Tuesday, December 29, 2009, a trademark application was filed for AKVEDA with the United States Patent and Trademark Office. The USPTO has given the AKVEDA trademark a serial number of 79078135. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, December 29, 2019. This trademark is owned by Novartis AG. The AKVEDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in dermatology, oncology, nephrology, hematology, in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations for the treatment of diabetes, anti-infective preparations, anti-viral preparations, antibiotics and antifungal preparations; vaccines; diagnostic preparations for medical use, excluding dermatological preparations and nutritional supplements
akveda

General Information

Serial Number79078135
Word MarkAKVEDA
Filing DateTuesday, December 29, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, December 29, 2019
Registration Number3892761
Registration DateTuesday, December 21, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 5, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in dermatology, oncology, nephrology, hematology, in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparations for the treatment of diabetes, anti-infective preparations, anti-viral preparations, antibiotics and antifungal preparations; vaccines; diagnostic preparations for medical use, excluding dermatological preparations and nutritional supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, December 27, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, January 19, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Tuesday, January 19, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, April 27, 2018NOTIFICATION PROCESSED BY IB
Friday, September 29, 2017NOTIFICATION PROCESSED BY IB
Thursday, January 12, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, January 12, 2017DEATH OF INTERNATIONAL REGISTRATION
Monday, April 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, April 19, 2011FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 19, 2011FINAL DISPOSITION PROCESSED
Monday, March 21, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 21, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, October 5, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2010PUBLISHED FOR OPPOSITION
Thursday, September 2, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 2, 2010ASSIGNED TO LIE
Tuesday, August 24, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 24, 2010EXAMINER'S AMENDMENT ENTERED
Tuesday, August 24, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 24, 2010EXAMINERS AMENDMENT E-MAILED
Tuesday, August 24, 2010EXAMINERS AMENDMENT -WRITTEN
Sunday, August 15, 2010ATTORNEY REVIEW COMPLETED
Wednesday, July 14, 2010ASSIGNED TO EXAMINER
Tuesday, July 13, 2010LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Friday, June 18, 2010LIMITATION OF GOODS RECEIVED FROM IB
Thursday, June 10, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 10, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 7, 2010REFUSAL PROCESSED BY IB
Thursday, May 6, 2010NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 29, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 29, 2010REFUSAL PROCESSED BY MPU
Saturday, March 27, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 26, 2010NON-FINAL ACTION WRITTEN
Friday, March 26, 2010NEW REPRESENTATIVE AT IB RECEIVED
Thursday, March 25, 2010ASSIGNED TO EXAMINER
Tuesday, February 23, 2010APPLICATION FILING RECEIPT MAILED
Wednesday, February 17, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 12, 2010LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, February 11, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

akveda preparations system pharmaceutical treatment disorders diseases anti prevention viral diabetes